Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Youjin Oh"'
Autor:
Bhoomika Sukhadia, MD, Dean Tan, BA, BS, Youjin Oh, MD, Zunairah Shah, MD, Young Kwang Chae, MD, MPH, MBA
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100520- (2024)
IDH2 gain-of-function mutations cause DNA hypermethylation interfering with cellular differentiation and are linked to poor disease outcomes in NSCLC. IDH2-inhibitor enasidenib is approved for refractory acute myeloid leukemia but has been associated
Externí odkaz:
https://doaj.org/article/19831a8ca6a14d10bc58dd48f0004a12
Autor:
Youjin Oh, Sung Mi Yoon, Jeeyeon Lee, Joo Hee Park, Soowon Lee, Timothy Hong, Liam Il‐young Chung, Sumedha Sudhaman, Timothy Riddell, Charuta C. Palsuledesai, Michael Krainock, Minetta C. Liu, Young Kwang Chae
Publikováno v:
Thoracic Cancer, Vol 15, Iss 13, Pp 1095-1102 (2024)
Abstract Background Circulating tumor DNA (ctDNA) has emerged as a prognostic and predictive biomarker for detection of minimal residual disease (MRD), monitoring treatment response, and early detection of recurrence in cancer patients. In this study
Externí odkaz:
https://doaj.org/article/2756170525d0413ebe1b183d96a92a3b
Autor:
Youjin Oh, Grace Yoon, Michael Maier, Bruno Reversade, Jessie Cameron, Susan Blaser, Cynthia Hawkins
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 101168- (2024)
Externí odkaz:
https://doaj.org/article/0c3457b103b34492827f462dbb0b1338
Autor:
Youjin Oh, Joo Hee Park, Trie Arni Djunadi, Zunairah Shah, Liam Il-Young Chung, Young Kwang Chae
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Treating advanced thyroid cancer presents challenges due to its resistance to various treatment modalities, thereby limiting therapeutic options. To our knowledge, this study is the first to report the efficacy of temsirolimus in conjunction with dua
Externí odkaz:
https://doaj.org/article/cacd928ef062467d9aad10606ea7a03c
Autor:
Jooyeon Lee, Inhyeok Lee, Youjin Oh, Jeong Woo Kim, Yeongkeun Kwon, Ahmad Alromi, Mohannad Eledreesi, Alkadam Khalid, Wafa Aljarbou, Sungsoo Park
Publikováno v:
Medicina, Vol 60, Iss 3, p 518 (2024)
Anti-reflux surgery (ARS) is an efficient treatment option for gastroesophageal reflux disease (GERD). Despite growing evidence of the efficacy and safety of ARS, medications including proton pump inhibitors (PPIs) remain the most commonly administer
Externí odkaz:
https://doaj.org/article/258f774cfe234c2aba60298cd4a7c90d
Autor:
Young Kwang Chae, Myungwoo Nam, Youjin Oh, Leeseul Kim, Timothy Hong, Liam Il-Young Chung, Soowon Lee, Sung Mi Yoon, Trie Arni Djunadi, Taegyu Um, Jeeyeon Lee, Maria Jose Aguilera Chuchuca, Madeline Jenkin, Jisang Yu, Hyeonseon Kim, Moataz Soliman, Nicolo Gennaro, Zunairah Shah, Cecilia Nam, Yury S Velichko, Haseok Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0a1faa207d784474a8cfd8929fd9c96f
Autor:
Young Kwang Chae, Myungwoo Nam, Youjin Oh, Leeseul Kim, Timothy Hong, Liam Il-Young Chung, Soowon Lee, Sung Mi Yoon, Trie Arni Djunadi, Taegyu Um, Jeeyeon Lee, Maria Jose Aguilera Chuchuca, Peter Haseok Kim, Madeline Jenkin, Jisang Yu, Hyeonseon Kim, Moataz Soliman, Nicolo Gennaro, Zunairah Shah, Cecilia Nam, Yury S Velichko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e08860ca48044797a44edc9098e6ad1d
Autor:
Youjin Oh, Eun-Seon Yoo, Sang Hyeon Ju, Eunha Kim, Seulgi Lee, Seyun Kim, Kevin Wickman, Jong-Woo Sohn
Publikováno v:
PLoS Biology, Vol 21, Iss 8, p e3002252 (2023)
It is well known that the neuropeptide Y (NPY)/agouti-related peptide (AgRP) neurons increase appetite and decrease thermogenesis. Previous studies demonstrated that optogenetic and/or chemogenetic manipulations of NPY/AgRP neuronal activity alter fo
Externí odkaz:
https://doaj.org/article/7d0ef672eebf4fadb1b0eb0244cebc5d
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract Although proximal gastrectomy (PG) provides superior nutritional outcomes over total gastrectomy (TG) in upper-third early gastric cancer (EGC), surgeons are reluctant to perform PG due to the high rate of postoperative reflux. This meta-ana
Externí odkaz:
https://doaj.org/article/5318b2bbba2b4f4aa460180302c31777
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/88c5232ba975460081c126180212ef24